To develop a highly sensitive and selective selected-reaction monitoring– mass spectrometric immunoassay analysis (SRM-MSIA)-based method for the concurrent detection and quantification of full-length parathyroid hormone (PTH) [amino acid (aa)1–84] and two N-terminal variants [aa7–84 and aa34–84] for clinical research use.
United States
